Dr. Potti’s former mentor and professor of cancer genomics, Joseph Nevins, PhD, told “60 Minutes” that Dr. Potti had manipulated data to support his theory that genomics could be used to treat tumors.
Dr. Potti resigned from the Institute for Genome Sciences and Policy and the School of Medicine in November 2010 following claims he had falsified qualifications on applications for federal funding and his resume, according to the report.
Currently, there are two pending lawsuits against Dr. Potti, Duke and others related to his research. The university is also conducting an ongoing investigation of Dr. Potti.
Dr. Nevins collaborated and co-authored several research papers with Dr. Potti. His statement on “60 Minutes” was the first time he indicated Dr. Potti intentionally falsified data.
Related Articles on Hospital Oncology:
Senator, Oncology Groups Urge Pharma to Boost Production of Pediatric Cancer Drug
Cadence Health in Illinois Affiliates With Cleveland Clinic for Cancer Care
Duke Medicine in North Carolina to Open $230M Cancer Center
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
